DK359486A - Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed - Google Patents

Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed Download PDF

Info

Publication number
DK359486A
DK359486A DK359486A DK359486A DK359486A DK 359486 A DK359486 A DK 359486A DK 359486 A DK359486 A DK 359486A DK 359486 A DK359486 A DK 359486A DK 359486 A DK359486 A DK 359486A
Authority
DK
Denmark
Prior art keywords
genes
metastase
forget
metastatic
tumors
Prior art date
Application number
DK359486A
Other languages
Danish (da)
English (en)
Other versions
DK359486D0 (da
Inventor
Shelly C Bernstein
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of DK359486D0 publication Critical patent/DK359486D0/da
Publication of DK359486A publication Critical patent/DK359486A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK359486A 1984-11-30 1986-07-29 Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed DK359486A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30
PCT/US1985/002323 WO1986003226A1 (en) 1984-11-30 1985-11-26 Transmissible, mammalian genes associated with tumor metastasis

Publications (2)

Publication Number Publication Date
DK359486D0 DK359486D0 (da) 1986-07-29
DK359486A true DK359486A (da) 1986-07-29

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK359486A DK359486A (da) 1984-11-30 1986-07-29 Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed

Country Status (13)

Country Link
EP (1) EP0203970A1 (OSRAM)
JP (1) JPS62501399A (OSRAM)
AU (1) AU5197986A (OSRAM)
DK (1) DK359486A (OSRAM)
ES (1) ES8705043A1 (OSRAM)
FI (1) FI863095L (OSRAM)
GR (1) GR852864B (OSRAM)
HU (1) HUT41837A (OSRAM)
IL (1) IL77157A0 (OSRAM)
NO (1) NO863066L (OSRAM)
PT (1) PT81584B (OSRAM)
WO (1) WO1986003226A1 (OSRAM)
ZA (1) ZA859070B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
CA2067797C (en) * 1989-10-18 1997-03-04 Charles R. King Production and use of human nm23 protein and antibodies therefor
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
EP0870057B1 (en) * 1995-11-16 2003-09-24 The Baylor College Of Medicine Method for identifying metastatic sequences
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
DE69730411T2 (de) * 1996-01-10 2005-09-01 The University Of Liverpool Metastasen induzierende dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
AU734476B2 (en) 1997-11-05 2001-06-14 Baylor College Of Medicine Sequences for targeting metastatic cells
CA2323074A1 (en) 1998-03-13 1999-09-16 Baylor College Of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
EP0203970A1 (en) 1986-12-10
ZA859070B (en) 1986-07-30
PT81584A (en) 1985-12-01
IL77157A0 (en) 1986-04-29
ES549438A0 (es) 1987-04-16
GR852864B (OSRAM) 1986-03-28
WO1986003226A1 (en) 1986-06-05
PT81584B (en) 1987-04-07
FI863095A7 (fi) 1986-07-29
DK359486D0 (da) 1986-07-29
FI863095A0 (fi) 1986-07-29
NO863066L (no) 1986-09-29
FI863095L (fi) 1986-07-29
AU5197986A (en) 1986-06-18
NO863066D0 (no) 1986-07-29
ES8705043A1 (es) 1987-04-16
JPS62501399A (ja) 1987-06-11
HUT41837A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
DK359486A (da) Overfoerbare pattedyrgener forbundet med tumormetastase, fremg. til isolering deraf, proteiner som generne koder for, antistoffer over for disse, sonder for generne og for mrna transkriberet derfra og fremg. til bedoemmelse af tumorers metastatiske tilboejelighed
DK110885A (da) Nucleinsyre-proteinkonjugater, disses anvendelse samt fremgangsmaade til fremstilling heraf
DK73483A (da) Dna-sekvenser, rekombinant-dna-molekyler samt fremgangsmaader til fremstilling af human-immune interferonlignende polypeptider
NO891818D0 (no) T4-reseptor-protein, relaterte dna-sekvenser samt fremstilling derav.
DE3578190D1 (de) Test fuer nukleinsaeuresequenzen, insbesondere genetische veraenderungen.
FI871189A7 (fi) Geenikoettimien parannuksia.
IT1314250B1 (it) Proteine (iip) che interagiscono con il recettore igf-1 geni che lecodificano e loro impiego.
DE3585953D1 (de) Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine.
DE68924227D1 (de) DNA-Fragment.
DK375283D0 (da) Dna-sekvenser, rekombinations-dna-molekyler samt fremgangsmader til fremstilling af kvaegvaeksthormonlignende polypeptider
DE3574994D1 (de) Sandwichhybridisierungsverfahren zum nachweis von nukleotidsequenzen.
NL188869B (nl) Methode voor het bepalen van antigenen, alsmede testkit daarvoor.
DK108589D0 (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen samt dna-sekvenser, der koder for saadanne antistoffer
AP9901654A0 (en) Gene sequencer and methods.
EP0284362A3 (en) Molecular markers
DK108189D0 (da) Chimere antistoffer rettet mod humant carcinoembryonalt antigen og metal-chelater samt dna-sekvenser, der koder for saadanne antistoffer
DE3764273D1 (de) Kreiselpumpe zur foerderung heisser medien.
DK54184D0 (da) Dna-sekvenser,rekombinations-dna-molekyler samt fremgangsmaader til fremstilling af human(interleukin)to-lignende polipeptider
FI883763L (fi) Frigoering av vaerdens foersvarsmediatorer i biologiska vaetskor genom systematisk behandling med dubbelstraengat rna.
NL193784B (nl) Geïntegreerde brugschakeling, en werkwijze voor het vervaardigen daarvan.
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
ZA975588B (en) Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof.
DE69738803D1 (de) Apoptosis induzierendes protein und dieses kodierendes gen
EP0226888A3 (en) Monoclonal antibodies specific to galactosyltransferase isoenzyme ii and their use in cancer immunoassays
DE3485923D1 (de) Dna-gen, verfahren zu seiner herstellung und dieses gen enthaltendes plasmid.

Legal Events

Date Code Title Description
A0 Application filed
AHB Application shelved due to non-payment